MANTOVANI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 43
AS - Asia 39
EU - Europa 38
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 5
Totale 139
Nazione #
US - Stati Uniti d'America 40
SG - Singapore 19
RU - Federazione Russa 15
CN - Cina 8
IE - Irlanda 8
SE - Svezia 4
FR - Francia 3
TH - Thailandia 3
VN - Vietnam 3
BR - Brasile 2
CA - Canada 2
GB - Regno Unito 2
IN - India 2
AR - Argentina 1
AT - Austria 1
BY - Bielorussia 1
FI - Finlandia 1
HK - Hong Kong 1
IT - Italia 1
JM - Giamaica 1
LK - Sri Lanka 1
LT - Lituania 1
PH - Filippine 1
SA - Arabia Saudita 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 125
Città #
San Jose 18
Singapore 9
Dublin 8
Bangkok 3
Beijing 3
Columbus 3
Council Bluffs 3
Lauterbourg 3
Hanoi 2
New York 2
Nyköping 2
Orem 2
Santa Clara 2
Boardman 1
Caracas 1
Casier 1
Colombo 1
Dallas 1
Dhubri 1
El Campo 1
Glew 1
Hamburg 1
Helsinki 1
Hong Kong 1
Iqaluit 1
Jacksonville 1
Jeddah 1
Kingston 1
Minsk 1
Montevideo 1
Moscow 1
North York 1
Orlando 1
Princeton 1
Salvador 1
Statesboro 1
Stevenage 1
São Paulo 1
Talisay City 1
Vilnius 1
Wilmington 1
Totale 88
Nome #
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 60
EVOLUTION OF LIVER FIBROSIS IN TYPE 2 DIABETIC PATIENTS WITH NAFLD IN A FOLLOW-UP STUDY: POSSIBLE HEPATOPROTECTIVE EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS 29
Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness 28
SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: a five-year follow-up study 22
Totale 139
Categoria #
all - tutte 939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 0 2 1 0 1 0 0 0 1
2022/202312 2 0 1 0 0 1 0 0 8 0 0 0
2023/20242 0 0 0 0 0 2 0 0 0 0 0 0
2024/202512 3 0 1 0 0 1 0 1 5 0 1 0
2025/202689 0 1 1 3 8 12 25 14 12 7 2 4
2026/202712 6 6 0 0 0 0 0 0 0 0 0 0
Totale 139